BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21237264)

  • 1. Decrease of lymphoproliferative response by amphetamine is mediated by dopamine from the nucleus accumbens: influence on splenic met-enkephalin levels.
    Assis MA; Valdomero A; García-Keller C; Sotomayor C; Cancela LM
    Brain Behav Immun; 2011 May; 25(4):647-57. PubMed ID: 21237264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization to amphetamine occurs simultaneously at immune level and in met-enkephalin of the nucleus accumbens and spleen: an involved NMDA glutamatergic mechanism.
    Assis MA; Hansen C; Lux-Lantos V; Cancela LM
    Brain Behav Immun; 2009 May; 23(4):464-73. PubMed ID: 19486656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C; Abraini JH; David HN
    Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine triggers an increase in met-enkephalin simultaneously in brain areas and immune cells.
    Assis MA; Collino C; Figuerola Mde L; Sotomayor C; Cancela LM
    J Neuroimmunol; 2006 Sep; 178(1-2):62-75. PubMed ID: 16904191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior.
    Goto Y; Grace AA
    Nat Neurosci; 2005 Jun; 8(6):805-12. PubMed ID: 15908948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.
    Saurer TB; Carrigan KA; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Apr; 173(1-2):3-11. PubMed ID: 16364456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-induced 50 kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis.
    Thompson B; Leonard KC; Brudzynski SM
    Behav Brain Res; 2006 Mar; 168(1):64-73. PubMed ID: 16343652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-induced changes in dopamine receptors in early postnatal rat brain.
    Mukda S; Kaewsuk S; Ebadi M; Govitrapong P
    Dev Neurosci; 2009; 31(3):193-201. PubMed ID: 19145071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of medial prefrontal cortex dopamine in age differences in response to amphetamine in rats: locomotor activity after intra-mPFC injections of dopaminergic ligands.
    Mathews IZ; McCormick CM
    Dev Neurobiol; 2012 Nov; 72(11):1415-21. PubMed ID: 22081646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute ethanol administration on methionine-enkephalin expression and release in regions of the rat brain.
    Méndez M; Barbosa-Luna IG; Pérez-Luna JM; Cupo A; Oikawa J
    Neuropeptides; 2010 Oct; 44(5):413-20. PubMed ID: 20605629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of amphetamine-induced stereotyped behaviors during the acute response.
    Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1999 Feb; 288(2):699-709. PubMed ID: 9918578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
    Hall DA; Powers JP; Gulley JM
    Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
    Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
    Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleus accumbens noradrenaline release.
    Vanderschuren LJ; Wardeh G; De Vries TJ; Mulder AH; Schoffelmeer AN
    J Neurosci; 1999 May; 19(10):4123-31. PubMed ID: 10234040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.